Your prediction
Pros and Cons of Nymox Pharmaceutical Corp. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nymox Pharmaceutical Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nymox Pharmaceutical Corp. | - | - | - | - | - | - | - |
| Enwave Corporation | -5.930% | -5.932% | -3.478% | 62.044% | -5.932% | -21.277% | -74.801% |
| Aurinia Pharmaceuticals Inc. | 0.700% | -1.690% | -5.115% | 70.213% | -4.974% | 52.272% | 16.258% |
| Spectral Medical Inc | - | 0.565% | 14.103% | 174.691% | 11.950% | 247.656% | 250.394% |
Comments
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NYMX provided by MarketBeat